Why Taser (TASR) Stock Is Plummetiing Today

NEW YORK (TheStreet) -- Taser International (TASR) shares are falling, down -5.4% to $16.18 on Wednesday, following the release of the company's first quarter earnings report.

The company posted net sales of $36.2 million, or 6 cents per share, beating analysts estimates by 2 cents.

Must Read: Warren Buffett's 10 Favorite Growth Stocks 

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. 

Year over year quarterly revenues increased 18.9% to $36.2 million, beating analysts estimates of $34.03 million in quarterly revenue.

The stock is experiencing this dip despite those positive numbers.

The loss may be attributed to an EBITDA drop to $7.2 million from $7.7 million in the year ago period, or a 7.6% decrease in income from operations to $4.9 million.

TheStreet Ratings team rates TASER INTERNATIONAL INC as a Buy with a ratings score of B-. TheStreet Ratings Team has this to say about their recommendation:

"We rate TASER INTERNATIONAL INC (TASR) a BUY. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value."

If you liked this article you might like

Fed Crashes the Party: Cramer's 'Mad Money' Recap (Wednesday 4/5/17)

Axon Is Offering Free Body Cameras to Police Officers

Axon Stock Rising, Offers Free Body Camera to U.S. Police

Axon Enterprise Stock Rising on 'Big News' From CEO Smith

Taser, AMD, Amgen, Old Republic :'Mad Money' Lightning Round (3/30/17)